Hints and tips:
Related Special Reports
...“Decades later, a V-neck sweater worn with a white round-neck T-shirt underneath is still one of my favourite looks. It’s clean, uncomplicated and blissfully under-thought.”...
...Last week, first lady Jill Biden tested positive for the virus, while US president Joe Biden, now in India for the G20 summit, tested negative multiple times, according to the White House....
...“Nobody at Pfizer ever told Mr Dagar, who was on the ‘blinded’ side, the results of the Paxlovid trial,” he added....
...But a senior White House official said the Biden administration was “not backing down” in the face of legal challenges....
...But the White House’s tough approach on antitrust makes large deals much riskier....
...Joe Biden has contracted Covid-19 and has started taking Pfizer’s antiviral pill to combat the disease, the White House announced.The 79-year-old US president tested positive on Thursday morning, according...
...In this week’s episode, we hear from White House Covid coordinator Ashish Jha, professor of molecular medicine and cardiologist Eric Topol and the FT’s US pharmaceuticals correspondent Jamie Smyth on what...
...The White House has warned it will take more than six months to fulfil its initial order for Pfizer’s antiviral Covid-19 pill, as officials damped speculation the drug could immediately turn the tables on...
...The Korean Wave opens September 24, V&A ‘Make, Break, Remix: The Rise of K-Style’ by Fiona Bae, (Thames & Hudson), will be published in the UK & Ireland on 22 September 2022...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...amazingly hands on”, according to one former Trump administration official, and unusually “personally involved” with discussions with people up and down the government, including at the regulator and the White...
...In early March 2020, Pfizer’s chief scientific officer was summoned to the White House to discuss the disease that was sweeping across the world....
...Individuals Most innovative Law firm leader Ira Coleman, McDermott, Will & Emery Most Innovative legal practitioner Arif Ali, Dechert Most Innovative Law firm change maker Michael Hertz, White & Case...
...Biden is due to meet business leaders at the White House on Wednesday as he looks to drum up corporate support for his administration’s new vaccine mandates....
...Mikael Dolsten, Pfizer’s chief scientific officer, told investors that the US drugmaker is “very intrigued by the use of mRNA for flu” because it can generate a good response from T cells, white blood cells...
...So I would just say, it would be better to wait your turn in line,” the 78-year-old US president said in remarks from the White House on Friday, adding that he would get his own booster as soon as he could...
...As we take our seats, the Pfizer supremo asks whether I drink. “A white wine,” he suggests. “Something dry.” When the waiter starts running us through the options by the glass, he interrupts him....
...Pfizer’s share price rose 2.5 per cent in New York on Monday, while BioNTech’s shares jumped 9.6 per cent....
...“The producers and buyers of NFTs are overwhelmingly white and male,” says Tokini Peterside, founder of the Art X Lagos fair....
...the scientific evidence does not yet justify giving most people third shots of messenger RNA vaccines, offers an insight into the internal tensions in the Biden administration that were ignited by the White...
...Neither the White House nor the US health department responded to requests to comment on the rollout of booster shots....
...Jeff Zients, head of the White House’s Covid-19 task force, said during a press briefing that, if approved, the pill would be an “additional tool in our toolbox” to address the pandemic....
...“Only 1.3 per cent of people in low-income countries are vaccinated, while the White House has no real strategy to deliver the 14bn doses the world needs to end this crisis.”...
...David Kessler, chief science officer to the White House coronavirus task force, told a Congressional committee: “I think we should expect that we may have to boost . . . and the current thinking is that...
...Another biotech, GL Rapha, will produce doses of Russia’s Sputnik V jab for global use. Additional reporting by Sherry Fei Ju in Beijing...
International Edition